BeOne Medicines CEO John Oyler disposes of $27,267,619 in common shares
ONC•CEO reports option exercises and share sales
BeOne Medicines CEO John Oyler reported option exercises on July 10-13, then sold the resulting American Depositary Shares.
- Disposed of 79,200 ADS in total at weighted-average prices near USD 296.07-307.41 per ADS.
- Directly held ADS position fell to zero following the sales.
- Exercised options for 782,834 ordinary shares at an exercise price of USD 2.84 per share.
Related News
Pro-Dex director Angelita Domingo disposes of 998 common shares worth $47,145.52
PDEX•
Crescent Biopharma Inc Prices Its Underwritten Public Offering Of 8,094,793 Ordinary Shares At $14.50 Per Share
CBIO•
